Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 307INDUSTRY 115NIH 19OTHER_GOV 12NETWORK 2UNKNOWN 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Lymphoid 263Gastrointestinal 252Gynecologic 242Breast 237Other hematologic neoplasm 228Genitourinary 227Thoracic 206CNS 202Sarcoma 186Head & Neck 113Plasma cell 91Dermatologic 68Other solid neoplasm 52Myeloid 43Tumor-Agnostic 21Other neoplasm 18Classical hematology 17Endocrine 16Other 10NET 2

Conditions

Neuroendocrine Tumors 2Vipoma 1Somatostatinoma 1Neoplasms 1Insulinoma 1Glucagonoma 1Gastrinoma 1Carcinoma, Islet Cell 1Adenoma, Islet Cell 1

Interventions

motesanib diphosphate 1batifiban 1Octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Interventional × NET × Clear all
NCT06345079 2025-08-14

STOPNET

Australasian Gastro-Intestinal Trials Group

Phase 2 Recruiting
78 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT00427349 2023-07-05

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

Eastern Cooperative Oncology Group

Phase 2 Completed
46 enrolled 7 charts
EndocrineNET

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡